Holen Sie sich die Stockscreener-App
49.43
4.33%
2.12
Handel nachbörslich:
49.46
0.03
+0.06%
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
WGS stock slumps after hours as firm predicts lower test volume for year - MSN
GeneDx a new overweight at Piper Sandler on rare diseases testing market - MSN
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - The Motley Fool
Prosight Management Acquires $42.72 Million Stake in GeneDx Holdings - Intellectia AI
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% - The Motley Fool
Casdin, Meister disclose sizable GeneDx (WGS) ownership positions - Stock Titan
WGS News | GENEDX HOLDINGS CORP (NASDAQ:WGS) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp.WGS - PR Newswire
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares? - Yahoo Finance
Casdin Partners master fund buys $21.5 million in GeneDx stock By Investing.com - Investing.com South Africa
Casdin Partners master fund buys $21.5 million in GeneDx stock - Investing.com India
Casdin-linked funds add 500K GeneDx (WGS) shares in open-market buys - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
GeneDx Holdings (WGS) price target decreased by 32.59% to 98.94 - MSN
Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud - marketscreener.com
GeneDx Holdings Corp. (WGS) Securities Fraud InvestigationLevi & Korsinsky - Morningstar
GeneDx Holdings Corp.Class A Common Stock (NQ: WGS - The Chronicle-Journal
GeneDx (WGS) 10K Form and Latest SEC Filings 2026 - MarketBeat
GeneDx faces securities fraud probe after missing revenue targets and stock plunges 49%. - Pluang
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Law firm investigates GeneDx after shares plunge 50% on weak earnings and lowered guidance - Pluang
Bragar Eagel & Squire, P.C. is Investigating GeneDx - GlobeNewswire
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Does GENEDX HOLDINGS (WGS) Have the Potential to Rally 26.17% as Wall Street Analysts Expect? - MSN
GeneDx Holdings Insider Bought Shares Worth $13,765,345, According to a Recent SEC Filing - marketscreener.com
A Look At GeneDx Holdings (WGS) Valuation After Q1 2026 Reset And Securities Investigation - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdin - The National Law Review
(WGS) Risk Channels and Responsive Allocation - Stock Traders Daily
Comerica Bank Sells 29,753 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Fraud Probes And Guidance Cut Put Valuation Gap In Focus - simplywall.st
Number of shareholders of GeneDx Holdings Corp. – NASDAQ:WGS - TradingView
A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities Investigation - Yahoo Finance
GeneDx Holdings (WGS) upgraded to strong buy: Here's what you should know - MSN
UBS Group AG Decreases Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Corvex management, director Keith Meister buy $13.7m GeneDx stock By Investing.com - Investing.com South Africa
Corvex management, director Keith Meister buy $13.7m GeneDx stock - Investing.com India
Corvex-linked funds boost GeneDx (WGS) stake with 351K-share open-market buy - Stock Titan
Casdin and Meister report 12% and 17.9% GeneDx (WGS) stakes - Stock Titan
GeneDx (NASDAQ:WGS) Shares Up 6.9%Still a Buy? - MarketBeat
GeneDx WGS Slides On Guidance Cut As Insiders Buy The Dip - StocksToTrade
GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth - MSN
GeneDx Q1 2026 misses targets; lower-margin genomic tests slow growth, but turnaround potential remains. - Pluang
1.43%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):